A detailed history of Dynamic Technology Lab Private LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 14,376 shares of BMRN stock, worth $957,872. This represents 0.11% of its overall portfolio holdings.

Number of Shares
14,376
Holding current value
$957,872
% of portfolio
0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$69.02 - $93.84 $992,231 - $1.35 Million
14,376 New
14,376 $1.01 Million
Q4 2023

Feb 09, 2024

BUY
$76.22 - $98.51 $636,055 - $822,065
8,345 New
8,345 $805,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $357,121 - $413,236
4,120 New
4,120 $357,000
Q4 2022

Feb 13, 2023

SELL
$80.93 - $108.63 $292,157 - $392,154
-3,610 Reduced 25.95%
10,300 $1.07 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $1.14 Million - $1.35 Million
13,910 New
13,910 $1.18 Million
Q2 2022

Aug 12, 2022

SELL
$71.48 - $86.85 $1.21 Million - $1.47 Million
-16,890 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $1.25 Million - $1.57 Million
16,890 New
16,890 $1.3 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $761,620 - $961,743
-11,300 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $264,833 - $309,494
3,296 Added 41.18%
11,300 $968,000
Q1 2019

May 13, 2019

BUY
$84.2 - $98.62 $399,023 - $467,360
4,739 Added 145.15%
8,004 $711,000
Q4 2018

Feb 13, 2019

SELL
$80.14 - $106.07 $564,265 - $746,838
-7,041 Reduced 68.32%
3,265 $278,000
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $967,939 - $1.09 Million
10,306 New
10,306 $1 Million
Q1 2018

May 14, 2018

SELL
$77.67 - $92.63 $450,486 - $537,254
-5,800 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$80.76 - $95.13 $274,584 - $323,442
3,400 Added 141.67%
5,800 $517,000
Q3 2017

Nov 08, 2017

SELL
$80.6 - $94.95 $133,070 - $156,762
-1,651 Reduced 40.76%
2,400 $223,000
Q2 2017

Aug 17, 2017

BUY
N/A
4,051
4,051 $368,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.